SYRE Stock-Based Compensation
Spyre Therapeutics Inc · Stock-Based Compensation
SYRE Stock-Based Compensation
Latest reported$45.70Mperiod ending
SYRE TTM Stock-Based Comp ($147.00K → $45.70M)
TTM stock-based compensation
High-resolution chart · PNG
SYRE stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 45,695,000 | |
| 41,561,000 | |
| 37,614,000 | |
| 37,019,000 | |
| 40,553,000 | |
| 39,857,000 | |
| 44,833,000 | |
| 52,887,000 | |
| 44,572,000 | |
| 37,801,000 | |
| 25,675,000 | |
| 9,832,000 | |
| 6,613,000 | |
| 6,719,000 | |
| 7,111,000 | |
| 7,778,000 | |
| 8,319,000 | |
| 8,382,000 | |
| 8,038,000 | |
| 7,556,000 | |
| 7,145,000 | |
| 6,665,000 | |
| 6,256,000 | |
| 5,828,000 | |
| 5,498,000 | |
| 5,143,000 | |
| 4,876,000 | |
| 5,069,000 | |
| 4,775,000 | |
| 4,526,000 | |
| 4,280,000 | |
| 3,601,000 | |
| 3,257,000 | |
| 2,926,000 | |
| 2,492,000 | |
| 2,052,000 | |
| 1,758,000 | |
| 1,482,000 | |
| 1,221,000 | |
| 1,382,000 | |
| 1,112,000 | |
| 869,000 | |
| 767,000 | |
| 417,000 | |
| 256,000 | |
| 185,000 | |
| 147,000 |